[1] Stone HB et al. Radiat Res, 1993; 136:422~434.
[2] Nunn A et al. Eur J Nucl Med, 1995; 22(3):265~80.
[3] Edwards DI. J Antimicrob Chemother, 1993;31:9~20.
[4] Yeh SH et al. Eur J Nucl Med, 1996; 23(10):1378~1383.
[5] DissmaInn PD et al. Chir Forum Exp Klin Forsch, 1997:221~227.
[6] Lim JL et al. J Nucl Med, 1994; 35:6 P.
[7] Shine CY et al. J Labelled Compd Radio Pharm, 1997; 39:70.
[8] Jelong JM et al. J Labelled Compd Radio-pharm, 1997; 39:349.
[9] Schneider RF et al. Quarterly J Nucl Med,1995; 39(1):41.
[10] Schneider RF et al. J Labelled Compd Radio-pharm, 1997; 39(7):541~547.
[11] Cowan DSM et al. Br J Cancer, 1996; 74(Sup-pl):S264~S266.
[12] Okada RD et al. Eur J Nucl Med, 1996; 23(4):443~447.
[13] Linder ICE et al. J Labened Compd Radio-pharm, 1995; 37:202.
[14] Kuczynski B et al. J Nucl Cardio, 1995; 4:S 28(abs).
[15] Howard W et al. J Nucl Med, 1998; 39(4):598~607.
[16] Zhang Z et al. J Labelled Compd Radiophann,1995; 37:205.
[17] Zhang Z et al. J Nucl Med, 1994; 35:472.
[18] Archer CM et al. Technetium labelled agents for imaging tissue hypoxia in vivo. In:Nicoli-ni Met al, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Padova, I-taly:SGE Ditoriali Publishers:1995; 535~539.
[19] Okada RD et al. Circulation, 1997; 95(7):1892~1899.
[20] Okada RD et al. Circulation, 1998; 97(25):2557~2566.
[21] Fukuchi K et al. Eur J Nucl Med, 1998; 25(4):361~366.
[22] Cook GJR et al. J Nucl Med, 1998; 39(1):99~103.
[23] Taniuchi H et al. J Nucl Med, 1997; 38(7):1130~1134.
[24] Shelton M E et al. J Nucl Med, 1989; 30(11):1843~1847.
[25] Blower PJ et al. Nucl Med Biol, 1996; 23:957~980.
[26] Fujibayashi Y et al. J Nucl Med, 1997; 38(7):1155~1160.
[27] Jason L JD et al. Eur J Nucl Med, 1998; 25(7):788~792.